1. Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA-21 expression, Akt and the Bcl-2/Bax pathway
    Ning Ma et al, 2016, Molecular Medicine Reports CrossRef
  2. BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism
    Hongyi Zhou et al, 2022, Clinical and Translational Medicine CrossRef
  3. Biodegradable nanoparticle-assisted and multiplexed imaging of asymmetric RNA expressions in live cells for precise cancer diagnosis and prognosis
    Xia Li et al, 2020, Nanoscale CrossRef
  4. Hypoxia‐responsive miRNA‐21‐5p inhibits Runx2 suppression by targeting SMAD7 in MC3T3‐E1 cells
    Lujun Li et al, 2019, Journal of Cellular Biochemistry CrossRef
  5. MicroRNAs: New players in pharmacotherapy for ischemic heart diseases?
    Pengzhou Hang et al, 2015, International Journal of Cardiology CrossRef
  6. Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls
    Carola Steudemann et al, 2013, BMC Veterinary Research CrossRef
  7. MicroRNA-21 mediates the protective role of emulsified isoflurane against myocardial ischemia/reperfusion injury in mice by targeting SPP1
    Ji Yuan et al, 2021, Cellular Signalling CrossRef
  8. Trimetazidine in Heart Failure
    Hongyang Shu et al, 2021, Frontiers in Pharmacology CrossRef
  9. Right Ventricle and Epigenetics: A Systematic Review
    Victoria Toro et al, 2023, Cells CrossRef
  10. Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress
    Md Sayed Ali Sheikh et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
  11. Efficacy of trimetazidine – an inhibitor of free fatty acids oxidation in the treatment of patients with stable angina pectoris and heart failure
    M. G. Bubnova et al, 2021, Kardiologiia CrossRef
  12. Trimetazidine prevents palmitate-induced mitochondrial fission and dysfunction in cultured cardiomyocytes
    Jovan Kuzmicic et al, 2014, Biochemical Pharmacology CrossRef
  13. Mitochondrial Dysfunction in Pulmonary Hypertension
    Gusty Rizky Teguh Ryanto et al, 2023, Antioxidants CrossRef
  14. Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia
    Amal A. Abd-El-Fattah et al, 2013, Cell Biochemistry and Biophysics CrossRef
  15. Effects of Trimetazidine on Right Ventricular Function and Ventricular Remodeling in Patients with Pulmonary Artery Hypertension: A Randomised Controlled Trial
    Hugo E. Verdejo et al, 2023, Journal of Clinical Medicine CrossRef
  16. Trimetazidine and Cardioprotection
    Konstantinos Tsioufis et al, 2015, Angiology CrossRef